User:Reph-415

Hi I have tons of sexual intercourse all the time.
 * Contributions
 * How to slap someone through the internet report
 * This article about phenyltropanes looks like it was edited by someone high on phenyltropanes, check it out

to do

 * Transistor ladder filter, diode ladder filter, OTA filter - or just expanding the voltage controlled filter article. - Currently in my sandbox !!


 * Iboluteine (ibogaine pseudoindoxyl) - An ibogaine oxydation product, analogous to the poorly studied opioid mitragynine pseudoindoxyl. Iboluteine and related metabolites possibly contribute to iboga's therapeutic effects. UPDATE : Unfortunately, research about iboga and its alkaloids has come to a crawling stop because of insane anti-drug propaganda from france and north america.

Tryptamines

 * Serotonin
 * Baeocystin, Norbaeocystin
 * O-4310
 * 6-Fluoro-DET
 * Tabernanthalog
 * PHA-57378
 * PNU-22394
 * Lisuride (ergoline)
 * PNU-181731 (isotryptamine)
 * AAZ-A-154 (isotryptamine)

Mescaline analogs

 * 2,5-dimethoxy-phenethylamine (2C-H)
 * 2,5-dimethoxyamphetamine (2,5-DMA or DOH)
 * 2,5-dimethoxy-phenylisobutylamine (4C-H)
 * 2,5-dimethoxy-4-fluorophenethylamine (2C-F)
 * 2,5-dimethoxy-4-fluoroamphetamine (DOF)
 * 2,5-dimethoxy-4-phenylisobutylamine (4C-F)

Others

 * (R)-69 (3IQ)
 * IHCH-7113
 * RH-34

List of atypical monoamine transporter ligands
There are many similar and/or contradicting hypotheses about monoamine transporter binding sites, here are some of them.

SERT

 * SERT NAMs : paroxetine and escitalopram (see allosteric serotonin reuptake inhibitor)
 * SERT NAM / "partial releaser" : 4-Trifluoromethyl-Methcathinone (4-TFMMC) CID:71550921
 * SERT PAM / "reuptake enhancer" : tianeptine (putative)
 * SERT PAM / "reuptake enhancer" : compound 7a CID:71462111

NET

 * NET NAM / "partial releaser" : αET (Emax ~ 75%)

DAT

 * Difluoropine, "inward-facing" reuptake inhibitor
 * Vanoxerine, "inward-facing" reuptake inhibitor
 * Modafinil, "inward-facing" reuptake inhibitor
 * SoRI-20041, "antagonist-like" reuptake inhibitor that, counterintuitively, doesn't antagonize dextroamphetamine-mediated (transporter-mediated) dopamine release.

Others

 * Selegiline, (-)-PPAP, and (-)-BPAP, "monoamine release enhancers"
 * PCP and RTI-4793-14 bind to an allosteric modulator site on monoamine transporters : PCP site 2